Roche launches dual antigen and antibody diagnostic test for hepatitis c
ZURICH (Reuters) – Roche has launched an new twin antigen and antibody diagnostic take a look at for hepatitis C, the Swiss prescribed drugs firm mentioned on Monday, which it says will give an earlier prognosis of the virus.
The Elecsys HCV Duo is the primary commercially accessible immunoassay that permits the simultaneous and unbiased willpower of the hepatitis C virus standing from a single human plasma or serum pattern.
In 2019, 58 million individuals on this planet have been dwelling with power hepatitis C an infection, however solely 21% have been conscious of it, in accordance with World Well being Group information. The illness can result in demise from situations together with cirrhosis and liver failure.
(Reporting by John Revill; Enhancing by Kim Coghill)
